2-isocyano-6-methylpyridine | 1270131-03-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-isocyano-6-methylpyridine
• 英文别名: 6-methyl-2-pyridyl isonitrile
• CAS: 1270131-03-7
• 化学式: C₇H₆N₂
• 分子量: 118.138
• InChiKey: SEYLCJGXASFZGV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  17.2
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-isocyano-6-methylpyridine 以 1,4-二氧六环 为溶剂， 以61%的产率得到1,7-dimethylpyrido[2'',1'':2',3']imidazo[4',5':4,5]imidazo[1,2-a]-pyridine
  参考文献：
  名称：

  Dimerization of 2-pyridylisonitriles produces π-extended fused heteroarenes useful as highly selective colorimetric and optical probes for copper ion

  摘要：

  A very simple synthesis of pyrido[2 '',1 '':2',3']imidazo[4',5':4,5]imidazo[1,2-a]Pyridines 2 was achieved from the dimerization of 2-pyridylisonitriles. The optical responses of these pi-extended fused heteroarenes to a series of metal ions were investigated by means of UV-visible absorption spectrum in acetonitrile. It was found that most of compounds 2 selectively responded to Cu2+, and the limit of detection was about 3.5 x 10(-7) M when using the best probe, 3,9-dimethylpyrido[2",1":2',3']imidazo[4',5':4,5] imidazol1,2-a]pyridine 2d. Meanwhile some compounds 2 specifically showed a color change from colorless to red or yellow when they are exposed to copper ion in acetonitrile, whereas other transitional, alkali and alkaline earth metal ions could not induce a color change. This work not only established a direct access to pi-extended fused heteroarenes, but also supplied novel sensitive and selective colorimetric and optical probes for copper ion. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2010.06.096
• 作为产物：
  描述：

  N-(6-methylpyridin-2-yl)formamide 在 三乙胺 、 三氯氧磷 作用下， 以 二氯甲烷 为溶剂， 以60%的产率得到2-isocyano-6-methylpyridine
  参考文献：
  名称：

  2-溴-6-异氰基吡啶是用于多组分化学的通用可转换异氰酸酯

  摘要：

  据报道2-异氰基吡啶是用于多组分化学的新型可转化异氰酸酯。对该类别的12位代表进行的比较显示，就稳定性和合成效率而言，2-溴-6-异氰基吡啶是最佳试剂。它在碱性和酸性条件下都具有足够的亲核性和所得酰胺部分的良好离去基团能力。为了证明该试剂的实用性，提出了有效的两步有效合成有效的阿片样物质芬太尼。

  DOI：

  10.1021/acs.orglett.6b00091

文献信息

• POTASSIUM CHANNEL MODULATORS
  申请人：Cadent Therapeutics, Inc.

  公开号：US20170355708A1

  公开（公告）日：2017-12-14

  Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with potassium channels. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.

  提供的是公式(I)的新颖化合物： 以及它们的药用可接受盐，这些化合物用于治疗与钾通道相关的一系列疾病、障碍或状况。还提供了包含公式(I)的新颖化合物的药物组合物，它们的药用可接受盐，以及使用它们来治疗与钾通道相关的一种或多种疾病、障碍或状况的方法。
• COMPOUNDS USEFUL AS LIGANDS AND PARTICULARLY AS ORGANIC CHROMOPHORES FOR COMPLEXING LANTHANIDES AND APPLICATIONS THEREOF
  申请人：Giraud Marion

  公开号：US20110112289A1

  公开（公告）日：2011-05-12

  The invention relates to the use of compounds comprising at least one 2-(1H-tetrazol-5-yl)pyridine unit, of formula (I) below: as ligands for lanthanides and, more especially, as organic chromophores for complexing these elements. It also relates to lanthanide complexes using these compounds as complexing organic chromophores, and to new compounds containing one or more 2-(1H-tetrazol-5-yl)pyridine units, which are useful as ligands for lanthanides and, in particular, as organic chromophores for complexing these elements. Applications: photonics and optoelectronics, especially for forming light-emitting devices such as electroluminescent diodes; biology, as for example for the preparation of luminescent probes.

  本发明涉及使用包含至少一个2-(1H-四唑-5-基)吡啶单元的化合物，其化学式如下所示，作为镧系元素的配体，更特别地，作为这些元素的有机荧光团。同时，还涉及使用这些化合物作为有机荧光团形成镧系元素配合物，以及含有一个或多个2-(1H-四唑-5-基)吡啶单元的新化合物，这些化合物可作为镧系元素的配体，尤其是作为这些元素的有机荧光团。应用领域包括光子学和光电子学，特别是用于制造发光器件如电致发光二极管；生物学，例如用于制备发光探针。
• COMPOUNDS AND THEIR METHODS OF USE
  申请人：Lemieux Rene M.

  公开号：US20140142081A1

  公开（公告）日：2014-05-22

  Compounds and compositions comprising compounds that inhibit glutaminase are described herein. Also described herein are methods of using the compounds that inhibit glutaminase in the treatment of cancer.

  本文描述了含有抑制谷氨酸酶的化合物和组合物。本文还描述了利用这些抑制谷氨酸酶的化合物治疗癌症的方法。
• Nitrogen-containing heterocyclic compound and use thereof
  申请人：Ikeura Yoshinori

  公开号：US20090156572A1

  公开（公告）日：2009-06-18

  The present invention relates to a compound represented by the formula wherein ring A is a nitrogen-containing heterocycle optionally further having substituent(s), ring B is an aromatic ring optionally having substituent(s), ring C is a cyclic group optionally having substituent(s), R 1 is a hydrogen atom, a hydrocarbon group optionally having substituent(s), an acyl group, a heterocyclic group optionally having substituent(s) or an amino group optionally having substituent(s), R 2 is an optionally halogenated C 1-6 alkyl group, m and n are each an integer of 0 to 5, m+n is an integer of 2 to 5, and is a single bond or a double bond, or a salt thereof and the like. Since the compound has a superior tachykinin receptor antagonistic action, and is useful as an agent for the prophylaxis or treatment of various diseases such as lower urinary tract diseases, gastrointestinal diseases, central nervous system diseases and the like.

  本发明涉及一种由下式表示的化合物：其中环A是含氮杂环，可选择地进一步具有取代基，环B是芳香环，可选择地具有取代基，环C是环状基团，可选择地具有取代基，R1是氢原子，一个碳氢基团，可选择地具有取代基，酰基，一个杂环基团，可选择地具有取代基或一个氨基团，可选择地具有取代基，R2是可选择卤代的C1-6烷基基团，m和n分别是0到5的整数，m+n是2到5的整数，是单键或双键，或其盐等。由于该化合物具有优越的催吐肽受体拮抗作用，可用作预防或治疗多种疾病的药物，如下尿道疾病、胃肠道疾病、中枢神经系统疾病等。
• Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds
  申请人：Cai R. Zhenhong

  公开号：US20080076738A1

  公开（公告）日：2008-03-27

  Novel HIV integrase inhibitor compounds having at least one phosphonate group, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.

  本发明公开了至少具有一个膦酸酯基团的新型HIV整合酶抑制剂化合物、其受保护的中间体以及用于抑制HIV整合酶的方法。